Smith & Nephew bets on technology that ‘sees through the skin’

The Telegraph have published an article announcing the £2.5…

OCT in the Clinic!

We are delighted to announce that VivoSight OCT…

Michelson Diagnostics closes £2.5 million First Tranche of £4.0 million

Michelson Diagnostics, the UK based medical device company…

Michelson Diagnostics launches new improved version of VivoSight OCT scanner with Micro-Camera to aid skin cancer diagnosis

Michelson Diagnostics, the UK based medical device company focused…

VivoSight sessions at EADV Conference in Amsterdam

Michelson Diagnostics are delighted to announce 2 fabulous…

Michelson to exhibit at EADV Conference 8-12 October

We are looking forward to exhibiting at the…

VivoSight OCT scanner, images and data to be presented at ADO Hautkrebs 2014, Frankfurt Am Main, 11-13th September 2014

Professor Julia Welzel, Chief Physician at Dept. of…

Michelson Diagnostics to present at Fortbildungswoche, Munich

Michelson Diagnostics, the UK based medical device company…

New study on non-invasive diagnosis of non-melanoma skin cancer with Melanoma Institute of Australia

Michelson Diagnostics, the UK based medical device company…